Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute

Journal of Investigative Dermatology

Volumn 126, Issue 1, 2006, Pages 128-136

  Li, Yunyuan ^a   Tredget, Edward E ^a   Ghaffari, Abdi ^a   Lin, Xiaoyue ^a   Kilani, Ruhangiz T ^a   Ghahary, Aziz ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; COLLAGEN; INDOLEAMINE 2,3 DIOXYGENASE; TRYPTOPHAN;

ACCELERATION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CELL TRANSPLANTATION; COCULTURE; CONTROLLED STUDY; COW; DEPLETION; EXPERIMENTAL MODEL; FETUS; FIBROBLAST; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKIN GRAFT; SKIN TRANSPLANTATION; T LYMPHOCYTE; WOUND; WOUND HEALING; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; CAPILLARIES; COLLAGEN; FIBROBLASTS; GELS; GRAFT REJECTION; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SKIN, ARTIFICIAL; TRYPTOPHAN; WOUND HEALING;

EID: 33644766944     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700022     Document Type: Article

References (48)

1. Bell E, Ivarsson B, Merrill C (1979) Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 76:1274-8
2. Bishop ET, Bell GT, Bloor S, Broom IJ, Hendry NFK, Wheatley DN (1999) An in vitro model of angiogenesis: basic features. Angiogenesis 3:335-44
3. Black AF, Berthod F, L'Heureux N, Germain L, Auger FA (1998) In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J 12:1331-40
4. Boyce ST, Supp AP, Harriger MD, Greenhalgh DG, Warden GD (1995) Topical nutrients promote engraftment and inhibit wound contraction of cultured skin substitues in arrythmic mice. J Invest Dermatol 104:345-9
5. Clemens MJ (2001) Initiation factor elF2 alpha phosphorylation in stress responses and apoptosis. Prog Mol Subcell Biol 27:57-89
6. Crosby JS, Chefalo PJ, Yeh I, Ying S, London IM, Leboulch P et al. (2000) Regulation of hemoglobin synthesis and proliferation of differentiation erythroid cells by heme-regulated elF-2 alpha kinase. Blood 96:3241-8
7. Daley-Yates PT, Powell AP, Smith LL (1988) Pulmonary indoleamine 2,3-dioxygenase activity and its significance in the response of rats, mice, and rabbits to oxidative stress. Toxicol Appl Pharmacol 96:222-32
8. Davison MJ, Benn SI (1996) Regulation of angiogenesis and wound repair. In: Cellular and Molecular Pathogenesis. (Sirica AE, ed), Philadelphia: Lippincott-Raven, 79-97
9. Erdag G, Morgan JR (2004) Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts. Cell Transplant 13:701-12
10. Friberg M, Jennings R, Alsarraj M, Dessureault S, Cantor A, Extermann M et al. (2002) Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int J Cancer 101:151-5
11. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196:459-68
12. Ghahary A, Tredget EE, Shen Q, Kilani RT, Scott PG, Houle Y (2000) Mannose-6-phosphate/IGF-II receptors mediate the effects of IGF-1-induced latent transforming growth factor beta 1 on expression of type I collagen and collagenase in dermal fibroblasts. Growth Factors 17:167-76
13. Hayashi T, Beck L, Rossetto C, Gong X, Takikawa O, Takabayashi K et al. (2004) Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest 114:270-9
14. Hultman CS, Brinson GM, Siltharm S, deSerres S, Cairns BA, Peterson HD et al. (1996) Allogeneic fibroblasts used to grow cultured epidermal autografts persist in vivo and sensitize the graft recipient for accelerated second-set rejection. J Trauma 41:51-8
15. Isik S, Er E, Soysal Y, Imirzalioglu N (2003) Prolongation of skin xenograft survival with modified cultured fibroblasts. Plast Reconstr Surg 111:275-82
16. Lee GK, Park HJ, Macleod M, Chandler P, Munn DH, Mellor AL (2002) Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division. Immunology 107:452-60
17. Li Y, Tredget EE, Ghahary A (2004a) Cell surface expression of MHC class I antigen is suppressed in indoleamine 2,3-dioxygenase genetically modified keratinocytes: implications in allogeneic skin substitute engraftment. Hum Immunol 65:114-23
18. Li Y, Tredget EE, Kilani RT, Iwashina T, Karami A, Lin X et al. (2004b) Expression of indoleamine 2,3-dioxygenase in dermal fibroblasts functions as a local immunosuppressive factor. J Invest Dermatol 122:953-64
19. Lorimier S, Gillery P, Hornebeck W, Chastang F, Laurent-Maquin D, Bouthor S et al. (1996) Tissue origin and extracellular matrix control neutral protease activity in human fibroblast three-dimensional cultures. J Cell Physiol 168:188-98
20. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL (1999) Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Med Exp 189:1363-72
21. Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, Ron D et al. (2005) GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22:633-42
22. Munn DH, Sharma MD, Hou D, Baban B, Lee JR, Antonia SJ et al. (2004) Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 114:280-90
23. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B et al. (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191-3
24. Narumiya H, Zhang Y, Fernandez-Patron C, Guilbert LJ, Davidge ST (2001) Matrix metalloproteinase-2 is elevated in the plasma of women with preeclampsia. Hypertens Pregnancy 20:185-94
25. Nehls V, Herrmann R, Hûhnken M, Palmetshofer A (1998) Contact-dependent inhibition of angiogenesis by cardiac fibroblasts in three-dimension fibrin gels in vitro: implications for microvascular network remodeling and coronary collateral formation. Cell Tissue Res 293:479-88
26. Rao RV, Ellerby HM, Bredesen DE (2004) Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ 11:372-80
27. Rissau W (1997) Mechanisms of angiogenesis. Nature 386:671-4
28. Sahota PS, Burn JL, Brow NJ, Macneil S (2004) Approaches to improve angiogenesis in tissue-engineered skin. Wound Rep Regen 12:635-42
29. Sahota PS, Burn JL, Heaton M, Freedlander E, Suvarna SK, Brown NJ et al. (2003) Development of a reconstructed human skin model for angiogenesis. Wound Rep Regen 11:275-84
30. Schaffer CJ, Nanney LB (1996) Cell biology of wound healing. Int Rev Cytol 169:151-81
31. Schmidt P, Krook H, Maeda A, Korsgren O, Benda B (2003) A new murine model of islet xenograft rejection: graft destruction is dependent on a major histocompatibility-specific interaction between T-cells and macrophages. Diabetes 52:1111-18
32. Schneider BL, Pralong WF, Deglon N, Aebischer P (2004) Survival of encapsulated human primary fibroblasts and erythropoietin expression under xenogeneic conditions. Hum Gene Ther 7:669-80
33. Sengar RD (1996) Molecular framework for angiogenesis. Am J Pathol 149:1-7
34. Sher SE, Hull BE, Rosen S, Church D, Friedman L, Bell E (1983) Acceptance of allogeneic fibroblasts in skin equivalent transplants. Transplantation 36:552-7
35. Sood R, Porter AC, Olsen DA, Cavener DR, Wek RC (2000) A mammalian homologue of GCN2 protein kinase important for translational control by phosphorylation of eukaryotic initiation factor-2alpha. Genetics 154:787-801
36. Sun Y (1989) Indoleamine 2,3-dioxygenase - a new antioxidant enzyme. Mater Med Pol 21:244-50
37. Supp DM, Boyce ST (2002) Overexpression of vascular endothelial growth factor accelerates early vascularization and improves healing of genetically modified cultured skin substitutes. J Burn Care Rehab 23:10-20
38. Supp DM, Supp AP, Bell SM, Boyce ST (2000) Enhanced vascularization of cultured skin substitutes genetically modified to overexpress vascular endothelial growth factor. J Invest Dermatol 114:5-13
39. Supp DM, Wilson-Landy K, Boyce ST (2002) Human dermal microvascular endothelial cells form vascular analogs in cultured skin substitutes after grafting to athymic mice. FASEB J 16:797-804
40. Takikawa O, Kuroiwa T, Yamazaki F, Kido R (1988) Mechanism of interferon-γ action: characterization of indoleamine 2,3-dioxygenase in cultured human cells by interferon-γ and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J Biol Chem 263:2041-8
41. Taylor MW, Feng GS (1991) Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5:2516-22
42. Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, Simon H et al. (2002) Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 196:447-57
43. Uyttenhove C, Pilotte L, Theate I, Stroobant V, Colau D, Parmentier N et al. (2003) Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9:1269-74
44. Volpin D, Veis A (1971) Isolation and characterization of the cyanogen bromide peptides from the α1 and α2 chains of acid-soluble bovine skin collagen. Biochemistry 10:1751-5
45. Wek RC, Jackson BM, Hinnebusch AG (1989) Juxtaposition of domains homologous to protein kinases and histidyl-tRNA synthetases in GCN2 protein suggests a mechanism for coupling GCN4 expression to amino acid availability. Proc Natl Acad Sci USA 86:4579-83
46. Yoshida A, Anand-Apte B, Zetter BR (1996) Differential endothelial migration and proliferation top basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors 13:57-64
47. Young DM, Greulich KM, Weier HG (1996) Species-specific in situ hybridization with fluorochrome-labeled DNA probes to study vascularization of human skin grafts on athymic mice. J Burn Care Rehab 17:305-10
48. Zhang P, McGrath BC, Reinert J, Olsen DS, Lei L, Gill S et al. (2002) The GCN2 elF2 alpha kinase is required for adaptation to amino acid deprivation in mice. Mol Cell Biol 22:6681-8